25 10月 2019 by admin in UncategorizedComments New Biotechnology publication validates Crescendo Biologics’ platform as it moves towards the clinic
17 10月 2019 by admin in UncategorizedComments Syros Announces Update on Selective CDK7 Inhibitor Portfolio
07 10月 2019 by admin in UncategorizedComments Tempest Therapeutics Names Biopharmaceutical Executive Stephen Brady as President and Chief Operating Office
03 10月 2019 by admin in UncategorizedComments Arcellx Raises $85 Million in a Series B Financing to Advance its Intelligent Cell Therapy Platform
02 10月 2019 by admin in UncategorizedComments NextCure Announces Promotion of Timothy Mayer, Ph.D., to Chief Operating Officer
